Alphabet Inc.
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 100% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
26 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Portfolio Trend
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Technology | 34.3% | $1,376,202,240 |
| Financial Services | 26.7% | $1,071,117,949 |
| Industrials | 24.5% | $985,206,559 |
| Healthcare | 14.5% | $583,043,829 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PL | Planet Labs PBC | +3,306,252 | 35,248,893 | $985,206,559 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reducedSold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| DXCM | Dexcom Inc | 1,036,937 | $68,821,508 | |
| WGS | GeneDx Holdings Corp. | 22,711 | $2,953,792 | |
| EXAS | EXACT SCIENCES CORP | 23,205 | $2,356,699 | |
| QNCX | Quince Therapeutics, Inc. | 189,122 | $633,558 | |
| FULC | Fulcrum Therapeutics, Inc. | 14,262 | $161,303 | |
| RGEN | Repligen Corp | 383 | $62,758 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| CME |
Cme Group Inc.
Financial Services
|
NEW | 3,484,020 | $1,029,005,307 | 25.63% | |
| PL |
Planet Labs PBC
Industrials
|
Added | 35,248,893 | $985,206,559 | 24.53% | |
| ASTS |
AST SpaceMobile, Inc.
Technology
|
Held | 8,943,486 | $741,146,684 | 18.46% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 3,292,525 | $320,198,056 | 7.97% | |
| ARM |
Arm Holdings PLC /Uk
Technology
|
Held | 1,960,784 | $296,627,403 | 7.39% | |
| FRSH |
Freshworks Inc.
Technology
|
Held | 16,206,643 | $130,139,343 | 3.24% | |
| PATH |
UiPath, Inc.
Technology
|
Held | 7,034,337 | $78,081,140 | 1.94% | |
| TEM |
Tempus AI, Inc.
Healthcare
|
Held | 1,551,102 | $70,140,832 | 1.75% | |
| PAYP |
PayPay Corp
Technology
|
NEW | 3,125,000 | $66,687,500 | 1.66% | |
| GTLB |
Gitlab Inc.
Technology
|
Held | 2,724,712 | $58,962,767 | 1.47% | |
| PRME |
Prime Medicine, Inc.
Healthcare
|
Held | 16,562,498 | $57,637,493 | 1.44% | |
| LIFE |
Ethos Technologies Inc.
Financial Services
|
NEW | 3,770,156 | $42,112,642 | 1.05% | |
| MAZE |
Maze Therapeutics, Inc.
Healthcare
|
Held | 1,388,583 | $41,449,202 | 1.03% | |
| BBOT |
BridgeBio Oncology Therapeutics, Inc.
Healthcare
|
Held | 2,823,126 | $25,266,977 | 0.63% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Reduced | 1,564,173 | $15,563,521 | 0.39% | |
| GLUE |
Monte Rosa Therapeutics, Inc.
Healthcare
|
Reduced | 684,275 | $11,256,323 | 0.28% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Held | 241,264 | $9,706,050 | 0.24% | |
| SANA |
Sana Biotechnology, Inc.
Healthcare
|
Held | 2,812,500 | $8,100,000 | 0.20% | |
| BEAM |
Beam Therapeutics Inc.
Healthcare
|
Held | 321,604 | $7,663,823 | 0.19% | |
| LYEL |
Lyell Immunopharma, Inc.
Healthcare
|
Held | 293,256 | $5,882,715 | 0.15% | |
| OSCR |
Oscar Health, Inc.
Healthcare
|
Held | 481,988 | $5,528,402 | 0.14% | |
| FIG |
Figma, Inc.
Technology
|
Held | 215,582 | $4,557,403 | 0.11% | |
| SPRO |
Spero Therapeutics, Inc.
Healthcare
|
Held | 889,979 | $2,082,550 | 0.05% | |
| HYPR |
Hyperfine, Inc.
Healthcare
|
Held | 898,720 | $970,617 | 0.02% | |
| AUTL |
Autolus Therapeutics plc
Healthcare
|
Held | 698,262 | $963,601 | 0.02% | |
| TNYA |
Tenaya Therapeutics, Inc.
Healthcare
|
Held | 915,705 | $633,667 | 0.02% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.